Financials data is unavailable for this security.
View more
Year on year Saroja Pharma Industries India Ltd 's revenues fell -18.97% from 501.93m to 406.69m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 10.61m to 8.78m, a -17.19% decrease.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, cash reserves at Saroja Pharma Industries India Ltd fell by 423.00k. Cash Flow from Financing totalled 36.95m or 9.09% of revenues. In addition the company generated 10.25m in cash from operations while cash used for investing totalled 47.62m.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items dropped -5.68%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
